CIK 0001598646 · Non-accelerated filer<br>Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 260784194
- Phone
- 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-05 | VAN HEEK G JAN Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-12-05 | Laghrissi-Thode Fouzia Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-12-05 | Kupfer David Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-12-05 | HASLER HANS PETER Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-12-05 | Ahlholm Frederick W SVP, CFO and Secretary | Grant or award · Employee Stock Option (right to buy) | +47,500 | 47,500 | ||
| 2024-12-05 | Race Geoff President | Grant or award · Employee Stock Option (right to buy) | +95,000 | 95,000 | ||
| 2024-12-05 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2023-10-04 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +100,450 | 100,450 | ||
| 2023-10-04 | Race Geoff President | Grant or award · Employee Stock Option (right to buy) | +87,050 | 87,050 | ||
| 2023-10-04 | Ahlholm Frederick W SVP, CFO and Secretary | Grant or award · Employee Stock Option (right to buy) | +42,850 | 42,850 | ||
| 2023-09-27 | HASLER HANS PETER Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2023-09-27 | VAN HEEK G JAN Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2023-09-27 | HILLEMAN JERYL L Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2023-09-27 | Kupfer David Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2023-09-27 | Laghrissi-Thode Fouzia Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2023-05-02 | Luthringer Remy CEO | Sale | −3,641 | $3.76 | $14K | 68,994 |
| 2023-05-01 | Luthringer Remy CEO | Sale | −23,753 | $3.85 | $91K | 72,635 |
| 2023-05-01 | Race Geoff President | Sale | −22,082 | $3.85 | $85K | 51,324 |
| 2023-05-01 | Ahlholm Frederick W SVP, CFO and Secretary | Sale | −3,580 | $4.48 | $16K | 17,518 |
| 2023-04-28 | Luthringer Remy CEO | Grant or award | +88,077 | 96,388 |
Page 2 of 6 · 120 trades